Seeking Alpha

Jazz Pharmaceuticals (JAZZ -7%) receives an FDA warning letter describing multiple safety...

Jazz Pharmaceuticals (JAZZ -7%) receives an FDA warning letter describing multiple safety violations, including "failure to develop adequate written procedures for the surveillance, receipt, evaluation, and reporting of postmarketing adverse drug experiences to FDA."
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)